According to a market report by Lucintel, the future of the global adsorbed DTP vaccine market looks promising with opportunities in the hospital and clinic markets. The global adsorbed DTP vaccine market is expected to grow with a CAGR of 7.9% from 2025 to 2031. The major drivers for this market are the increasing prevalence of chronic disease and rising DTP infections.
A more
than 150-page report to understand trends, opportunity and forecast in global adsorbed
DTP vaccine market to 2031 by type (child and adult), application (hospitals
and clinics), and region (North America, Europe, Asia Pacific, and the Rest of
the World).
Lucintel
forecasts that, within the type category, child is expected to witness higher
growth over the forecast period.
Within the
application category, the hospital is expected to witness higher growth.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Download
sample by clicking on adsorbed DTP
vaccine market.
Sanofi
Pasteur, GSK, Serum Institute of India, Mitsubishi Tanabe Pharma, KM Biologics,
Panacea Biotec, Yuxi Watson Biotechnology are the major suppliers in the adsorbed DTP vaccine market.
This unique research report
will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Humanoid Robot GaN Device Market
No comments:
Post a Comment